1202891-16-4
1202891-16-4 structure
- Name: ARRY-502
- Chemical Name: (4S)-6-Chloro-7-(4-{[2-(4-chloro-2-methoxyphenyl)ethyl]carbamoyl}phenoxy)-4-chromanecarboxylic acid
- CAS Number: 1202891-16-4
- Molecular Formula: C26H23Cl2NO6
- Molecular Weight: 516.370
- Create Date: 2020-01-12 16:49:13
- Modify Date: 2025-09-24 06:22:54
-
ARRY-502 is an orally bioavailable, potent and selective antagonist of the prostaglandin D2 receptor (CRTh2) for treatment of mild to moderate Th2-driven asthma. Asthma Phase 2 Discontinued
| Name | (4S)-6-Chloro-7-(4-{[2-(4-chloro-2-methoxyphenyl)ethyl]carbamoyl}phenoxy)-4-chromanecarboxylic acid |
|---|---|
| Synonyms |
2H-1-Benzopyran-4-carboxylic acid, 6-chloro-7-[4-[[[2-(4-chloro-2-methoxyphenyl)ethyl]amino]carbonyl]phenoxy]-3,4-dihydro-, (4S)-
(4S)-6-Chloro-7-(4-{[2-(4-chloro-2-methoxyphenyl)ethyl]carbamoyl}phenoxy)-4-chromanecarboxylic acid |
| Description | ARRY-502 is an orally bioavailable, potent and selective antagonist of the prostaglandin D2 receptor (CRTh2) for treatment of mild to moderate Th2-driven asthma. Asthma Phase 2 Discontinued |
|---|---|
| References | References View Related Products by Target Prostaglandin Receptor Asthma |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 686.1±55.0 °C at 760 mmHg |
| Molecular Formula | C26H23Cl2NO6 |
| Molecular Weight | 516.370 |
| Flash Point | 368.8±31.5 °C |
| Exact Mass | 515.090271 |
| LogP | 4.95 |
| Vapour Pressure | 0.0±2.2 mmHg at 25°C |
| Index of Refraction | 1.619 |